Sílvia Saumell(@SSaumell_MD) 's Twitter Profile Photo

Finally our work of Multiomics in MSD patients with Micromegas was presented in (poster 4116). You did it perfect Miranda!!!

Finally our work of Multiomics in MSD patients with Micromegas was presented in #ASH2023 (poster 4116). You did it perfect Miranda!!!
account_circle
YomnaEissa(@YomnaEissa1) 's Twitter Profile Photo

Happy to have presented 2 posters in my first in person ASH meeting- looking at “Sorafenib maintenance post Allo HCT in FLT3-ITD AML patients with focus on dosage and FLT3-ITD AF” and “Outcomes of Allo HCT in elderly patients ≥ 70 years old”.

Happy to have presented 2 posters in my first in person ASH meeting- looking at “Sorafenib maintenance post Allo HCT in FLT3-ITD AML patients with focus on dosage and FLT3-ITD AF” and “Outcomes of Allo HCT in elderly patients ≥ 70 years old”. #ASH2023
account_circle
Atharva Karulkar(@atharvak03) 's Twitter Profile Photo

ImmunoACT's NexCAR19, India's first approved CAR-T cell therapy pivotal studies to be presented at
Key Highlights:
- 70% ORR
- No G3-4 CRS
- No Neurotoxicity
- No ICU admissions ,Overall low HCRU, median hospitalization of 7d, Ideal for LMICs

ImmunoACT's NexCAR19,  India's first approved CAR-T cell therapy pivotal studies to be presented at #ASH2023
Key Highlights:
- 70% ORR 
- No G3-4 CRS 
- No Neurotoxicity
- No ICU admissions ,Overall low HCRU, median hospitalization of 7d, Ideal for LMICs
account_circle
Amaya Llorente, MD(@amayallorente) 's Twitter Profile Photo

Hematological activity in primary antiphospholid syndrome ASH and ASH abstract achievement award. Come join us, poster 4008. Special thanks to my great team Rodrigo F. and Alfonso Orozco for making this possible.

Hematological activity in primary antiphospholid syndrome @ASH_hematology and ASH abstract achievement award. Come join us, poster 4008. Special thanks to my great team @Roy_fig and @AlfonsOrozC for making this possible. #ASH2023
account_circle
Valentina Restrepo, MD(@vale_restrepo1) 's Twitter Profile Photo

First presentation at a US conference! Honored to present our work on coagulopathy in venous malformations at 🩸
Forever grateful to my wonderful mentors Dr. Alfred Lee, Dr Alex Pine Alexander Pine Layla Van Doren ❤️
Yale Cancer Center Yale Hematology Oncology Fellows

First presentation at a US conference! Honored to present our work on coagulopathy in venous malformations at #ASH2023 🩸
Forever grateful to my wonderful mentors Dr. Alfred Lee, Dr Alex Pine @BenignHeme @LaylaDoren1 ❤️
@YaleCancer @YaleHemOnc
account_circle
Fadi Haddad, MD(@FadiHaddad_MD) 's Twitter Profile Photo

Honored to present at dasatinib+VEN in FL
💊 Dasatinib C1-C3 ➡️ Dasatinib+VEN x3 yrs ➡️ dasatinib only
🔹After 12 mo of combo: MMR 86%, MR4 53%
🔸Higher risk of neutropenia
⁉️ Similar outcomes compared to dasatinib alone
➡️ Longer F/U needed
MD Anderson Cancer Center

Honored to present at #ASH2023 dasatinib+VEN in FL  #CML
💊 Dasatinib C1-C3 ➡️ Dasatinib+VEN x3 yrs ➡️ dasatinib only
🔹After 12 mo of combo: MMR 86%, MR4 53%
🔸Higher risk of neutropenia
⁉️ Similar outcomes compared to dasatinib alone
➡️ Longer F/U needed
#leusm @MDAndersonNews
account_circle